Macquarie Equinox 6 Trust and Macquarie Atlas Trust raise more than $100 million from Australian retail investors

05 July 2005

Macquarie's Equity Markets Group today announced the successful closure of both their Macquarie Equinox 6 Trust and Macquarie Atlas Trust investment offerings.

Macquarie Equinox 6 Trust, the latest in the series of Macquarie Group's capital protected hedge fund offerings, but the first to be offered as an Australian Registered Managed Investment Scheme, raised more than $58million from retail investors.

As an investment that aims to profit in both rising and falling markets, Equinox 6 appealed to a broad range of investors, including individuals and self managed superannuation fund investors who were looking to make investments before the end of the financial year.

"We are delighted with the result. It has been our most successful raising to date, and far exceeded our expectations, given the large number of products being marketed at this time of year," said Cathy Kovacs, Division Director of Macquarie's Equity Markets Group.

Macquarie Atlas Trust is an investment offering capital protection and capital growth linked to the Australian share market with the potential for high income. It was offered for the first time to Australian investors and raised almost $46 million.

"This is a fantastic result and illustrates the appetite that currently exists within our market for capital protected investments of this nature,” said Pia Cooke, a Manager within the Equity Markets Group.

According to Ms. Cooke, investor interest was strong, with many individual investors choosing to invest in Macquarie Atlas through the 100% borrowing facility offered by Macquarie.

For further information, please contact:

Cathy Kovacs
Division Director
Equity Markets Group
Tel: (612) 8232 8683

Pia Cooke
Manager
Equity Markets Group
Tel: (612) 8232 6974

Important information

This general advice has been prepared by Macquarie Bank Limited ABN 46 008 583 542 ("Macquarie"). Units in Macquarie Equinox 6 Trust ARSN 113 966 500 ("Equinox") and Macquarie Atlas Trust ARSN 113 966 760 ("Atlas")-issued by Macquarie Portfolio Management Limited ACN 092 552 611 ("RE") were offered under Product Disclosure Statements ("PDS") available from www.macquarie.com.au. You should obtain a copy of the relevant PDS from RE relating to the units, in which you are interested, and consider it before making any decisions about whether to acquire, or continue to hold, those units. This advice does not take account of your objectives, financial situation or needs. Before acting on this general advice, you should therefore consider the appropriateness of the advice having regard to your situation. We recommend you obtain financial, legal and taxation advice before making any financial investment decision.

The information in this release has been prepared in good faith with all reasonable care, but is based on information from RE which has not been verified. To the extent permitted by law, Macquarie makes no warranty in relation to, or accepts any responsibility or liability for any loss or damage suffered by any person arising out of or in relation to this information.

RE is not an authorised deposit taking institution for the purposes of the Banking Act (Cth) and its obligations do not represent deposits or other liabilities of Macquarie or any other Macquarie Group company. Macquarie does not guarantee or otherwise provide assurance in respect of the obligations of RE. Investments in Equinox and Atlas are subject to investment risk, including possible delays in repayment and loss of income and capital invested. None of Macquarie, RE or any Macquarie Group company guarantees the performance of Equinox or Atlas, the repayment of capital from Equinox or Atlas or any particular rate of return.

Macquarie, or its associates, officers or employees may have interests in the financial products referred to in this information by acting in various roles. They may buy or sell the financial products as principal or agent and as such may effect transactions which are not consistent with any recommendations (if any). Macquarie or its associates may also receive fees or brokerage for acting in the above capacities.

Information current as at 5 July 2005.

Contact us

Please email us for all media enquiries